We are developing a convenient over-the-counter test that will be readily available to all men allowing them to check for early signs of prostate cancer. It boasts the following features:
• Provides Immediate results
• Miniature portable device
• Increased diagnostic accuracy on PSA
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer. A condition that is likely to affect 1 in 8 men at some stage of their lives.
Cambridge Oncometrix is developing a non-invasive test that will allow men to check the health of their prostate regularly. A simplified version of the test will be available for home use. A more advanced version will be used in medical institutions.
This test will be capable of accurately detecting aggressive forms of prostate cancer at the early stages of its development.
Perform proof-of-concept clinical study
Refine assay, develop test instrumentation
Qualify Biomarkers in a large clinical trial
Obtain regulatory approvals
Deliver the service to the medical institutions and to the home market
Together we will make a prostate cancer-free future reality for generations of men to come!
Copyright © Cambridge Oncometrix – 2016 - Contact